Search Results - "Umiker, Ben"
-
1
A Soluble Activin Receptor Type IIB Prevents the Effects of Androgen Deprivation on Body Composition and Bone Health
Published in Endocrinology (Philadelphia) (01-09-2010)“…Androgen deprivation, a consequence of hypogonadism, certain cancer treatments, or normal aging in men, leads to loss of muscle mass, increased adiposity, and…”
Get full text
Journal Article -
2
217 Evaluating biomarkers of JTX-8064 (anti-LILRB2/ILT4 monoclonal antibody) in an ex vivo human tumor histoculture system to inform clinical development
Published in Journal for immunotherapy of cancer (01-11-2020)“…BackgroundLeukocyte immunoglobulin-like receptor B2 (LILRB2; ILT4) is an immunoinhibitory protein expressed on the surface of myeloid cells that has been…”
Get full text
Journal Article -
3
Abstract 1727: Tumor associated macrophages and resistance to immune checkpoint blockade: consideration of cancer indications for the clinical development of JTX-8064, an anti-LILRB2/ILT4 monoclonal antibody
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Leukocyte immunoglobulin-like receptor B2 (LILRB2; ILT4) is expressed on myeloid cells and inhibits myeloid cell activation through binding Major…”
Get full text
Journal Article -
4
Inhibition of LILRB2 by a Novel Blocking Antibody Designed to Reprogram Immunosuppressive Macrophages to Drive T-Cell Activation in Tumors
Published in Molecular cancer therapeutics (03-04-2023)“…Tumor-associated macrophages (TAM) play an important role in maintaining the immunosuppressive state of the tumor microenvironment (TME). High levels of CD163+…”
Get full text
Journal Article -
5
Phase 1, first-in-human trial of JTX-8064, an anti-LILRB2/ILT4 monoclonal antibody, as monotherapy and in combination with anti-PD-1 in adult patients with advanced solid tumors (INNATE)
Published in Journal of clinical oncology (20-05-2021)“…Abstract only TPS2672 Background: Leukocyte Immunoglobulin-like receptor B2 [LILRB2; immunoglobulin-like transcript 4 (ILT4)] is an immunoinhibitory protein…”
Get full text
Journal Article -
6
Abstract 4532: Preclinical evaluation of JTX-1811, an anti-CCR8 antibody with enhanced ADCC activity, for preferential depletion of tumor-infiltrating regulatory T cells
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Introduction: Immune checkpoint blockade (ICB) has revolutionized the treatment of many cancers, still most patients do not respond to PD-1 or CTLA-4…”
Get full text
Journal Article -
7
945 Overlapping and distinct patterns of LILRB receptors support complementary targeting approach in cancer
Published in Journal for immunotherapy of cancer (01-11-2022)“…BackgroundLeukocyte immunoglobulin-like receptors (LILRBs) are cell surface immunoinhibitory proteins that have been recently recognized as therapeutic targets…”
Get full text
Journal Article